DY 268

Based on 2 publications in PubMed 9 10 2

Axon 2561

CAS [1609564-75-1]

MF C30H32N4O5S
MW 560.66

  • Purity: 100%
  • Soluble in DMSO

DY 268

Description

Highly potent FXR antagonist with a promising in vitro profile (IC50 values 7.5 nM and 468.5 nM in FXR binding assay and cell-based FXR antagonistic assay, respectively). DY 268 shows no FXR agonistic activity nor cytotoxicity, making it an excellent chemical tool to elucidate the biological function of FXR.

KEYWORDS: DY 268 | supplier | FXR antagonist | DY268 | CAS [1609564-75-1] | Chenodeoxycholic acid | FXR | Antagonist | Nuclear | Farnesoid X Receptor | cholesterol | metabolism

Highly potent FXR antagonist with a promising in vitro profile

Chemical name

1-(3-methoxybenzyl)-N-(4-methyl-3-(morpholinosulfonyl)phenyl)-3-p-tolyl-1H-pyrazole-4-carboxamide

Parent CAS No.

[1609564-75-1]

Order
Size Unit Price Stock
10 mg €120.00 In Stock
50 mg €450.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...